抗癫癎药物与Stevens-Johnson综合征和中毒性表皮坏死溶解症

被引:7
作者
王云峰
周忠蜀
机构
[1] 中日友好医院儿科
关键词
抗惊厥药; Stevens-Johnson综合征; 表皮坏死松解症,中毒性;
D O I
暂无
中图分类号
R742.1 [癫痫]; R725.9 [小儿全身性疾病];
学科分类号
100201 [内科学]; 100204 [神经病学];
摘要
Stevens-Johnson综合征(SJS)和中毒性表皮坏死溶解症(TEN)是两种严重的变应性疾病,其临床症状非常相似,互有交叉,均表现为高热、全身不适及快速进行性的皮肤斑丘疹和疱疹,常伴有黏膜损伤及内脏损害。导致SJS和TEN的关键性病理环节是外周血单个核细胞分泌的可溶性Fas配体与角化细胞表面表达的Fas受体相互作用,从而导致角化细胞凋亡及表皮损伤。SJS和TEN与芳香族抗癫癎药物(苯巴比妥、苯妥英钠、卡马西平)的应用密切相关,也可由新型抗癫癎药物,如拉莫三嗪引起。研究显示,在抗癫癎治疗的最初8周内发生SJS和TEN的危险性最高。由于芳香族抗癫癎药物之间的交叉过敏性,一旦发生SJS和TEN而又必须继续抗癫癎治疗时,可改用丙戊酸钠或新型抗癫癎药物,由于它们的代谢途径和代谢产物与前者不同,通常是安全的。
引用
收藏
相关论文
共 9 条
[1]
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions [J].
Hung, Shuen-Lu ;
Chung, Wen-Hung ;
Jee, Shiou-Hwa ;
Chen, Wen-Chieh ;
Chang, Yun-Ting ;
Lee, Woan-Ruoh ;
hu, S-Ling Hu ;
Wu, Meng-Tse ;
Chen, Gwo-Shing ;
Wong, Tak-Wah ;
Hsiao, Pa-Fan ;
Chen, Wei-Hsuan ;
Shih, Han-Yu ;
Fang, Wu-Hsiang ;
Wei, Chun-Yu ;
Lou, Yi-Hui ;
Huang, Yau-Li ;
Lin, Juei-Jueng ;
Chen, Yuan-Tsong .
PHARMACOGENETICS AND GENOMICS, 2006, 16 (04) :297-306
[2]
Current treatments of epilepsy.[J].Siddhartha Nadkarni;Josiane LaJoie;Orrin Devinsky.Neurology.2005, 12 S
[3]
Carbamazepine - The commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: A study of 7 years.[J].K Devi;Sandhya George;S Criton;V Suja;P Sridevi.Indian Journal of Dermatology; Venereology; and Leprology.2005, 5
[4]
Risk of Stevens–Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.[J].Maja Mockenhaupt;John Messenheimer;Pat Tennis;Juergen Schlingmann.Neurology.2005, 7
[5]
Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study [J].
Lin, MS ;
Dai, YS ;
Pwu, RF ;
Chen, YH ;
Chang, NC .
INTERNAL MEDICINE JOURNAL, 2005, 35 (03) :188-190
[6]
Clinical evaluation and management of drug hypersensitivity [J].
Volcheck, GW .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2004, 24 (03) :357-+
[7]
Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand [J].
Abe, R ;
Shimizu, T ;
Shibaki, A ;
Nakamura, H ;
Watanabe, H ;
Shimizu, H .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (05) :1515-1520
[8]
Stevens-Johnson syndrome and antiepileptics [J].
Dunn, N ;
Wilton, L ;
Shakir, S .
LANCET, 1999, 354 (9183) :1033-1034
[9]
Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study [J].
Rzany, B ;
Correia, O ;
Kelly, JP ;
Naldi, L ;
Auquier, A ;
Stern, R .
LANCET, 1999, 353 (9171) :2190-2194